Meng Wu
Peking Union Medical College Hospital, Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, China
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Optimal Timing of Dupilumab Application in CRSwNP: Impact of "Neoadjuvant Therapy" on Surgical Outcomes at 1 Year.
Journal: International forum of allergy & rhinology
Published: April 09, 2025
Design, synthesis and activity evaluation of benzene sulfonamide derivatives as novel androgen receptor antagonist.
Journal: European journal of medicinal chemistry
Published: April 02, 2025
Discovery of the Clinical Candidate YY2201 as a Highly Potent and Selective ATR Inhibitor.
Journal: Journal of medicinal chemistry
Published: March 03, 2025
Design and Synthesis of Dual-Target Inhibitors Targeting Androgen Receptors and Glucocorticoid Receptors to Overcome Antiandrogen Resistance in Castration-Resistant Prostate Cancer.
Journal: Journal of medicinal chemistry
Published: February 22, 2024
Identifying Comprehensive Genomic Alterations and Potential Neoantigens for Cervical Cancer Immunotherapy in a Cohort of Chinese Squamous Cell Carcinoma of the Cervix.
Journal: Biomedical and environmental sciences : BES
Published: September 15, 2023
Synthesis and Antineoplastic Activity of a Dimer, Spiroindolinone Pyrrolidinecarboxamide.
Journal: Molecules (Basel, Switzerland)
Published: March 23, 2023
CDK7 inhibition induces apoptosis in acute myeloid leukemia cells and exerts synergistic antileukemic effects with azacitidine in vitro and in vivo.
Journal: Leukemia & lymphoma
Published: January 19, 2023
Ferroptosis-Related Long Noncoding RNAs Have Excellent Predictive Ability for Multiomic Characteristics of Bladder Cancer.
Journal: Oxidative medicine and cellular longevity
Published: June 09, 2022
Nonsense-mediated mRNA decay inhibition synergizes with MDM2 inhibition to suppress TP53 wild-type cancer cells in p53 isoform-dependent manner.
Journal: Cell death discovery
Published: April 23, 2022
Novel MDM2 Inhibitor XR-2 Exerts Potent Anti-Tumor Efficacy and Overcomes Enzalutamide Resistance in Prostate Cancer.
Journal: Frontiers in pharmacology
Published: February 08, 2022
Development of novel androgen receptor antagonists based on the structure of darolutamide.
Journal: Bioorganic chemistry
Published: November 08, 2021
Ferroptosis Mediation Patterns Reveal Novel Tool to Implicate Immunotherapy and Multi-Omics Characteristics in Bladder Cancer.
Journal: Frontiers in cell and developmental biology
Published: October 08, 2021
Last Updated: 09/26/2026